Mr. Gregory Norden
Senior Vice President,
Pharmaceutical technology
Greenberg Traurig
Israel
Biography
Mr. Gregory Norden (Greg) is an independent director of the Company. From 1989 to 2010, Mr. Norden held various senior positions with Wyeth/American Home Products, most recently as Wyeth’s Senior Vice President and Chief Financial Officer. Prior to this role, Mr. Norden was Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals. Prior to his affiliation with Wyeth, Mr. Norden served as Audit Manager at Arthur Andersen & Company. Mr. Norden also serves on the boards of directors of Royalty Pharma, a pharmaceutical company focused on acquiring revenue-producing intellectual property, Univision, a media company serving Hispanic America, and Zoetis, an animal health company. Mr. Norden is a former director of Welch Allyn (acquired by Hill-Rom in 2015), Lumara Health (acquired by AMAG Pharmaceuticals in 2014), and Human Genome Sciences (acquired by GlaxoSmithKline in 2012). Mr. Norden received a M.S. in Accounting from Long Island University - C.W. Post and a B.S. in Management/Economics from the State University of New York - Plattsburgh.
Research Interest
Biopharmaceutics and Biologic Drugs Nano Pharmaceutical Industry and Market Regulatory Aspects Towards Approval of Nanomedicine